Endo International has reached a “master settlement agreement” to resolve “all known” cases accusing the company of overstating the benefits of its testosterone replacement therapy and failing to warn men that use of the drug increases the risk for heart attacks, strokes and blood clots. Endo faces about 1,300 testosterone lawsuits, about 900 of which are pending in a federal multidistrict litigation in the Northern District of Illinois against Endo and several other testosterone manufacturers. Other testosterone cases are pending in the Philadelphia County Court of Common Pleas and other states. In February, Endo announced a tentative settlement agreement and ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.